Decision aids improved participants' informed decision making about prostate cancer screening but did not change the actual screening rates, a study found.
6 Aug 2013
Internists considering testosterone therapy are ideally positioned to consider a broader differential diagnosis that will actually help the patient.
1 May 2020
MKSAP Quiz: optimal management of coronary artery disease
9 Mar 2010
Prostate-specific antigen (PSA)-based screening significantly reduced mortality from prostate cancer but did not affect all-cause mortality, according to two more years of follow-up results in the European Randomized Study of Screening for Prostate Cancer.
20 Mar 2012
Surgery was associated with better survival than radiotherapy in men with non-metastatic prostate cancer, according to a large observational study with follow-up as long as 15 years.
11 Mar 2014
Gastroesophageal reflux disease, rectal bleeding, and chronic diarrhea can be controlled better by applying high-value care.
1 Jun 2017
No mortality benefit associated with primary androgen deprivation therapy in localized prostate cancer
Primary androgen deprivation therapy (PADT) yielded no mortality benefit compared with no PADT in men with clinically localized prostate cancer, according to a new study.
25 Mar 2014
Brigham and Women's Hospital has seen positive results from creating ambulatory safety nets for patients at risk for cancer.
1 Jan 2020
Docetaxel added to the start of hormone therapy for metastatic prostate cancer may prolong survival compared to patients who received hormone therapy alone, according to early results from a trial.
17 Dec 2013
An editorial called for personalized screening strategies that are tailored to a man's individual risk and preferences.
24 Nov 2015